Empresa Oramed Pharmaceuticals, Inc. Xetra
Acciones
OJU
US68403P1049
Biotecnología e investigación médica
Precio de cierre
Otros sitios de cotización
|
||
- EUR | - |
|
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical Solutions
100,0
%
| 3 | 100,0 % | 1 | 100,0 % | -50,43 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Israel
100,0
%
| 3 | 100,0 % | 1 | 100,0 % | -50,43 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Miriam Kidron
FOU | Founder | 83 | 12/04/02 |
Nadav Kidron
CEO | Chief Executive Officer | 50 | 12/04/02 |
Joshua Hexter
COO | Chief Operating Officer | 53 | 14/04/13 |
Leonard Sank
BRD | Director/Board Member | 59 | 23/10/07 |
Zach Herschfus
IRC | Investor Relations Contact | - | - |
Netanel Derovan
LAW | General Counsel | - | 09/01/22 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Nadav Kidron
CEO | Chief Executive Officer | 50 | 12/04/02 |
Miriam Kidron
FOU | Founder | 83 | 12/04/02 |
Leonard Sank
BRD | Director/Board Member | 59 | 23/10/07 |
Arie Mayer
BRD | Director/Board Member | 67 | 05/12/19 |
Benjamin Shapiro
BRD | Director/Board Member | 40 | 01/05/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 40 628 924 | 36 048 040 ( 88,73 %) | 0 | 88,73 % |
Información de la empresa
Oramed Pharmaceuticals, Inc.
1185 Avenue of the Americas 3rd Floor
10036, New York
+844 967 2633
http://www.oramed.com![Dirección Oramed Pharmaceuticals, Inc.(OJU)](https://cdn.zonebourse.com/static/address/493413.png)
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+38,66 % | 52,85 mil M | |
+35,57 % | 38,24 mil M | |
-7,81 % | 38,87 mil M | |
-10,77 % | 26,79 mil M | |
+11,77 % | 26,16 mil M | |
-17,82 % | 19,9 mil M | |
+35,09 % | 13,18 mil M | |
+29,17 % | 12,24 mil M | |
-3,05 % | 11,79 mil M |
- Bolsa de valores
- Acciones
- Acción ORMP
- Acción OJU
- Empresa Oramed Pharmaceuticals, Inc.